| Feature | MHC Class II Deficiency (n = 8) Median (range) or N |
CGD (n = 8) Median(range) or N |
|---|---|---|
| Age (years) | 1.71 (0.5-5.1) | 7.14 (5.1-11) |
| Gender (F/M) | 4/4 | 2/6 |
| MRD/MUD | 7/1 | 7/1 |
| Cumulative Busulfan level (mg/L.h) | 57 (50-70) | 52.7 (46-62) |
| Time to Neutrophil engraftment (days) | 24(16-30) | 20 (17-26) |
| Time to Platelet engraftment (days) | 33(25-65) | 18(17-47) |
| Infused nucleated cell dose (X 108/kg) | 5.7 (4-14) | 4.2 (1.1-7.5) |
| Infused CD34 cell dose (X 106/kg) | 12 (2.51-21.9) | 7.6 (3.3-10.7) |
| Acute GVHD Grade II-IV | 1 (grade II) | 1 (grade II) |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.